Changeflow GovPing Pharma & Life Sciences

Recent changes

GovPing tracks 141 sources for this role out of 2,348 total sources on GovPing, covering Guidance, Enforcement, Rule, Notice, and Consultation instruments. There were 722 changes in the last 7 days.

Health Canada issued a Type I recall for nitrous oxide chargers sold by DOODELZ, Gold Whip, and Whip-it! brands without market authorization, while the UK VMD called for a Class II recall of Zoetis's Scabigard Suspension for cutaneous administration. FDA classified Draeger's Atlan A350 anesthesia workstations as a Class I recall due to potential piston ventilator failure, and Morovan recalled approximately 4,000 units of Gel Nail Polish Remover for methylene chloride and chloroform contamination.

Favicon for recalls-rappels.canada.ca

Lifeworks Technology Massage Guns Recalled as Unauthorised Device

Health Canada has recalled Lifeworks Technology Vibra-Heal and Restore Massage Guns because they were distributed without a valid medical device licence. Sales have ceased, and the company plans to apply for the necessary licence.

Priority review Enforcement Medical Devices
1mo ago ECHA News
Favicon for echa.europa.eu

ECHA Biocidal Products Committee Opinions on Active Substances and Authorisations

The European Chemicals Agency's Biocidal Products Committee (BPC) adopted six opinions on active substances and two on Union authorisations in its February 2026 meeting. These opinions concern substances like ethanol, DMDMH, hydrochloric acid, C(M)IT/MIT, and peracetic acid, impacting various product types. The European Commission will make the final decisions.

Priority review Notice Environmental Protection
1mo ago ECHA News
Favicon for echa.europa.eu

Biocides Committee supports ethanol approval for disinfectants

ECHA's Biocidal Products Committee (BPC) has supported the approval of ethanol for use in human hygiene, general, and food/feed area disinfectants. The committee did not conclude on ethanol's carcinogenic or reprotoxic properties due to data limitations and the nature of existing evidence.

Priority review Guidance Environmental Protection
1mo ago ECHA News
Favicon for echa.europa.eu

ECHA Updates Annual Evaluation Statistics

The European Chemicals Agency (ECHA) has updated its statistics on chemical evaluation progress, reporting on compliance checks conducted between 2009 and 2025. The agency checked the compliance of over 30% of substances registered before 2019 at volumes of at least 100 tonnes per year, aiming to ensure reliable hazard data and chemical safety.

Routine Notice Environmental Protection
1mo ago ECHA News
Favicon for echa.europa.eu

ECHA Risk Assessment Committee Adopts PFAS Restriction Opinion

The European Chemicals Agency's Risk Assessment Committee (RAC) has adopted its opinion on a proposal to restrict all per- and polyfluoroalkyl substances (PFAS) across the EU/EEA. This opinion is a key step in the regulatory process, with the Socio-Economic Analysis Committee (SEAC) expected to release its draft opinion soon.

Priority review Guidance Environmental Protection
Favicon for www.fda.gov

Medline Industries Recalls Catheters Due to Particulates and Infection Risk

The FDA has identified a Medline Industries catheter recall as the most serious type due to potential particulates causing infection or embolism. Affected product lots must be destroyed. This is an expansion of a previous recall.

Urgent Enforcement Medical Devices
1mo ago CPSC Product Recalls
Favicon for www.cpsc.gov

Unique Brands Recalls Forever 21 Pajama Pants for Burn Hazard

Unique Brands is recalling approximately 230 units of Forever 21 Kids Disney Mickey Mouse Pajama Pants due to a burn hazard. The recalled sleepwear violates mandatory flammability standards for children's sleepwear, posing a risk of serious injury or death. Consumers are advised to stop using the product immediately and contact Unique Brands for a full refund.

Urgent Enforcement Product Safety
1mo ago CPSC Product Recalls
Favicon for www.cpsc.gov

Tomum Minoxidil Hair Serum Bottles Recalled Due to Child Poisoning Risk

The U.S. Consumer Product Safety Commission (CPSC) announced a recall of approximately 27,400 units of Tomum Minoxidil Hair Regrowth Treatment spray bottles due to a violation of the Poison Prevention Packaging Act. The bottles are not child-resistant, posing a serious poisoning risk to children. Belleka Inc. is offering a free replacement product.

Urgent Enforcement Product Safety
1mo ago CPSC Product Recalls
Favicon for www.cpsc.gov

HALO Dream Magic Sleepsuits Recalled Due to Choking Hazard

The U.S. Consumer Product Safety Commission (CPSC) announced a recall of approximately 45,000 HALO Dream Magic Sleepsuits due to a choking hazard. The zipper heads can detach from the garment, posing a risk to infants. Consumers are advised to stop using the product immediately.

Urgent Enforcement Product Safety
1mo ago CPSC Product Recalls
Favicon for www.cpsc.gov

Cubimana Building Sets Recalled Due to Battery Ingestion Risk

The U.S. Consumer Product Safety Commission (CPSC) announced the recall of approximately 3,950 Cubimana Island Storm 3 In 1 Building Sets sold on Amazon. The recall is due to a violation of the mandatory toy safety standard, as the battery compartment can be easily accessed by children, posing a risk of serious injury or death from battery ingestion.

Urgent Enforcement Product Safety

Showing 3831–3840 of 3,952 changes

1 382 383 384 385 386 396
RSS

Get daily alerts for pharma & life sciences

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

Filters

141 official sources tracked

Regs.gov: Food and Drug Administration

Updated 33m ago

USPTO Trademarks - Pharmaceuticals (Class 005)

Updated 11d ago

EPO Patent Bulletin - Therapeutics (A61P)

Updated 19m ago

USPTO Patent Applications - Pharma (A61K)

Updated 2d ago

USPTO Patent Applications - Biotech (C12N)

Updated 17h ago

ClinicalTrials.gov

Updated 2d ago

USPTO Patent Applications - Peptides (C07K)

Updated 2d ago

USPTO Patent Grants - Biotech (C12N)

Updated 20m ago

USPTO Patent Applications - Organic Chemistry (C07D)

Updated 4d ago

USPTO Patent Applications - Therapeutics (A61P)

Updated 2d ago

USPTO Patent Grants - Therapeutics (A61P)

Updated 19m ago

USPTO Patent Grants - Organic Chemistry (C07D)

Updated 12h ago

USPTO Patent Grants - Peptides (C07K)

Updated 7h ago

ANSM Drug & Device Safety Alerts

Updated 4m ago

FDA: Drug Recalls Class II

Updated 8d ago

FR: National Institutes of Health

Updated 5h ago

Health Canada Recalls & Safety Alerts

Updated 6m ago

Regs.gov: Centers for Medicare and Medicaid Services

Updated 22h ago

FR: Health and Human Services Department

Updated 5m ago

CPSC Product Recalls

Updated 13d ago

FR: Food and Drug Administration

Updated 5h ago

FR: Drug Enforcement Administration

Updated 12d ago

FDA Warning Letters

Updated 6d ago

MHRA Guidance & Safety

Updated 32m ago

FR: Centers for Disease Control and Prevention

Updated 1d ago

WHO News

Updated 3h ago

CMS Newsroom

Updated 5d ago

FR: Centers for Medicare & Medicaid Services

Updated 6m ago

Regs.gov: Occupational Safety and Health Administration

Updated 20h ago

DEA Press Releases

Updated 18d ago

DEA Public Safety Alerts

Updated 6d ago

Regs.gov: Animal and Plant Health Inspection Service

Updated 5d ago

FDA Recalls & Safety Alerts

Updated 17h ago

HSA Singapore Announcements

Updated 8d ago

FDA Medical Device Recalls

Updated 19m ago

Saudi SFDA News

Updated 21h ago

Regs.gov: Centers for Disease Control and Prevention

Updated 23h ago

FR: Health Resources and Services Administration

Updated 6d ago

Regs.gov: Food Safety and Inspection Service

Updated 11d ago

HHS OIG Reports & Publications

Updated 12d ago

ANSM France News

Updated 11m ago

FDA Press Releases

Updated 24h ago

WV Board of Pharmacy

Updated 10d ago

FDA MedWatch Safety Alerts

Updated 21d ago

USP Compendial Notices

Updated 12d ago

NH Board of Pharmacy Actions

Updated 12d ago

FDA Debarment List

Updated 9d ago

MS Board of Pharmacy News

Updated 27d ago

LA Board of Pharmacy News

Updated 27d ago

FDA Drug Recalls Class I

Updated 19d ago

KS Board of Pharmacy Newsletters

Updated 20d ago

GA Board of Pharmacy Board Orders

Updated 22d ago

FDA AI-Enabled Medical Devices

Updated 23d ago

BfArM Drug Safety Communications

Updated 3d ago

UK VMD

Updated 19m ago

NICE Technology Appraisals

Updated 7d ago

ECHA News

Updated 14d ago

FDA Guidance Documents

Updated 3h ago

USDA FSIS Recalls

Updated 14d ago

EMA News

Updated 15d ago

Frequently asked questions

What does this feed cover?

FDA warning letters, novel drug approvals, drug shortage notices, ICH guideline updates, USP notices, EMA news, DEA scheduling decisions, and TGA/WHO standards.

Who is this for?

Regulatory affairs professionals, pharmacovigilance teams, and medical affairs groups at pharma companies and CROs who need to track FDA and EMA actions.

How often is this updated?

GovPing checks source pages multiple times daily. FDA warning letters and drug approvals typically appear within hours of publication.

Does this cover EMA and international regulators?

Yes. We monitor the EMA, ICH, WHO, TGA (Australia), and other international health authorities alongside FDA.

How is this different from AgencyIQ?

AgencyIQ is a full FDA intelligence platform. GovPing is a free feed of the FDA, EMA, and ICH source pages where warning letters, approvals, drug shortages, and guidance are first published - AI-summarized with attention-level ratings on every change.

Is GovPing free?

Yes. GovPing is free, and always will be. We believe government regulatory data should be accessible to everyone. For custom monitoring of pages we don't cover yet, Changeflow starts at $99/mo.

Need to monitor something else?

GovPing covers the common sources. For niche pages specific to your team, add custom URL monitoring with Changeflow.

Get Pharma & Life Sciences alerts

Daily digest of pharma & life sciences regulatory changes. AI-summarized, no noise.

Free. Unsubscribe anytime.